Cover Image
Market Research Report
Product code 
1020114

North America Intraoperative Radiation Therapy Market- Industry Trends and Forecast to 2028

Published: | Data Bridge Market Research Private Limited | 100 Pages | Delivery time: 3-5 business days

Price

Back to Top
North America Intraoperative Radiation Therapy Market- Industry Trends and Forecast to 2028
Published: June 1, 2021
Data Bridge Market Research Private Limited
Content info: 100 Pages
Delivery time: 3-5 business days
  • ALL
  • Description
  • Table of Contents
Description

North America intraoperative radiation therapy market is projected to register a CAGR of 6.5% in the forecast period of 2021 to 2028. The new market report contains data for historic year 2019, the base year of calculation is 2020, and the forecast period is 2021 to 2028.

Market Segmentation:

North America Intraoperative Radiation Therapy Market By Method (Electron IORT, Intraoperative Brachytherapy, High Dose-Rate IORT, X-ray IORT and Others.), Product (Intraoperative Radiation Therapy Devices, Intraoperative Radiation Therapy Accessories And Software & Services) Type(Portable And Benchtop), Application (Breast Cancer, Brain Tumor, Head & Neck Cancer, Soft Tissue Sarcoma, Pediatric Tumors, Gynecological Cancer, Genitourinary Cancers, Upper Gastro-Intestinal Tumors Other Cancer) End User(Hospital, Ambulatory Surgical Centers, Specialty Center And Others) And Distribution Channel (Direct Tender And Retail Sales) Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028

Some of the major factors contributing to the growth of the North America intraoperative radiation therapy market are:

Growing collaboration of IORT market players with hospitals and other medical settings

Supporting reimbursement policies for cancer patients

Market Players:

Key market players operating in the North America intraoperative radiation therapy market are listed below:

IntraOp Medical, Inc.

Varian Medical Systems, Inc.,

Carl Zeiss AG

Eckert & Ziegler.

iCAD Inc.,

Sensus Healthcare

Elekta AB,

Brainlab AG

GMV

Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION 36

  • 1.1 OBJECTIVES OF THE STUDY 36
  • 1.2 MARKET DEFINITION 36
  • 1.3 OVERVIEW OF NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET 36
  • 1.4 LIMITATIONS 39
  • 1.5 MARKETS COVERED 39

2 MARKET SEGMENTATION 42

  • 2.1 MARKETS COVERED 42
  • 2.2 GEOGRAPHICAL SCOPE 43
  • 2.3 YEARS CONSIDERED FOR THE STUDY 44
  • 2.4 CURRENCY AND PRICING 44
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 45
  • 2.6 MULTIVARIATE MODELLING 48
  • 2.7 PRODUCT LIFELINE CURVE 49
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 50
  • 2.9 DBMR MARKET POSITION GRID 51
  • 2.10 MARKET APPLICATION METHOD COVERAGE GRID 52
  • 2.11 VENDOR SHARE ANALYSIS 53
  • 2.12 SECONDARY SOURCES 54
  • 2.13 ASSUMPTIONS 54

3 EXECUTIVE SUMMARY 55

4 PREMIUM INSIGHTS 58

5 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET: INDUSTRY INSIGHTS 59

  • 5.1 THE U.S. 59
  • 5.2 FRANCE 60
  • 5.3 GERMANY 61
  • 5.4 CHINA 62
  • 5.5 JAPAN 63
  • 5.6 INDIA 64
  • 5.7 BRAZIL 65
  • 5.8 SOUTH AFRICA 66

6 NEW PRODUCT LAUNCH- NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET 67

7 REGULATORY FRAMEWORK 70

8 MARKET OVERVIEW 71

  • 8.1 DRIVERS 73
    • 8.1.1 RISE IN PREVALENCE OF CANCER DISEASES 73
    • 8.1.2 RISE IN COLLABORATION AND AGREEMENT OF INTRAOPERATIVE RADIATION THERAPY MARKET PLAYERS WITH HOSPITALS AND OTHER MEDICAL SETTINGS 74
    • 8.1.3 RISE IN GERIATRIC POPULATION THAT ARE MOST VULNERABLE TO CANCER 75
    • 8.1.4 TECHNOLOGY ADVANCEMENT IN IORT 76
    • 8.1.5 SUPPORTING REIMBURSEMENT POLICIES FOR CANCER PATIENT 77
  • 8.2 RESTRAINTS 78
    • 8.2.1 RISK ASSOCIATED WITH HIGH DOSE RADIATION EXPOSURE 78
    • 8.2.2 CHALLENGES ASSOCIATED WITH BRAND EQUITY 78
  • 8.3 OPPORTUNITIES 79
    • 8.3.1 INCREASE IN THE NUMBER OF CLINICAL TRIALS OVER THE USE OF IORT 79
    • 8.3.2 INCREASE APPLICATION OF IORT IN VARIOUS CANCER TREATMENT 80
  • 8.4 CHALLENGES 81
    • 8.4.1 LACK OF SKILLED ONCOLOGIST 81
    • 8.4.2 HIGH COMPETITION AMONG KEY PLAYERS 81
    • 8.4.3 HIGH COST OF IORT TREATMENT 82

9 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD 83

  • 9.1 OVERVIEW 84
  • 9.2 X-RAY IORT 85
  • 9.3 INTRAOPERATIVE BRACHYTHERAPY 86
  • 9.4 HIGH DOSE-RATE IORT 87
  • 9.5 ELECTRON IORT 88
  • 9.6 OTHERS 89

10 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT 91

  • 10.1 OVERVIEW 92
  • 10.2 INTRAOPERATIVE RADIATION THERAPY DEVICES 93
    • 10.2.1 X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM 95
      • 10.2.1.1 X-Ray Brachytherapy System 96
      • 10.2.1.2 Mobile X-Ray Intraoperative Radiation Therapy System 96
      • 10.2.1.3 Others 96
    • 10.2.2 TREATMENT PLANNING SYSTEMS 96
    • 10.2.3 HDR AFTERLOADERS 96
    • 10.2.4 ELECTRON BEAM INTRAOPERATIVE RADIATION THERAPY SYSTEM 96
    • 10.2.5 ACCELERATORS 96
    • 10.2.6 OTHERS 96
  • 10.3 INTRAOPERATIVE RADIATION THERAPY ACCESSORIES 96
    • 10.3.1 APPLICATORS 99
      • 10.3.1.1 Surface Applicators 99
      • 10.3.1.2 Needle Applicators 99
    • 10.3.2 WORKSTATIONS 99
    • 10.3.3 GENERATORS 99
    • 10.3.4 FLAT APPLICATORS 99
    • 10.3.5 OTHERS 99
  • 10.4 SOFTWARES & SERVICES 99

11 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE 101

  • 11.1 OVERVIEW 102
  • 11.2 PORTABLE 103
  • 11.3 BENCHTOP 104

12 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION 107

  • 12.1 OVERVIEW 108
  • 12.2 BREAST CANCER 109
  • 12.3 GENITOURINARY CANCERS 110
    • 12.3.1 COLORECTAL CANCER 111
    • 12.3.2 PROSTATE CANCER 111
    • 12.3.3 RENAL CANCER 112
    • 12.3.4 BLADDER CANCER 112
    • 12.3.5 OTHERS 112
  • 12.4 SOFT TISSUE SARCOMA 112
  • 12.5 UPPER GASTRO-INTESTINAL TUMORS 113
    • 12.5.1 PANCREATIC CANCER 114
    • 12.5.2 GASTRIC CANCER 114
    • 12.5.3 OTHERS 114
  • 12.6 GYNAECOLOGICAL CANCER 115
  • 12.7 BRAIN TUMOR 116
  • 12.8 HEAD & NECK CANCER 117
  • 12.9 PAEDIATRICS TUMORS 119
  • 12.10 OTHERS CANCER 120

13 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER 122

  • 13.1 OVERVIEW 123
  • 13.2 HOSPITAL 124
  • 13.3 SPECIALTY CENTERS 125
  • 13.4 AMBULATORY SURGICAL CENTERS 125
  • 13.5 OTHERS 127

14 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL 128

  • 14.1 OVERVIEW 129
  • 14.2 DIRECT TENDER 130
  • 14.3 RETAIL SALES 131

15 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION 132

  • 15.1 NORTH AMERICA 132
    • 15.1.1 U.S. 139
    • 15.1.2 CANADA 143
    • 15.1.3 MEXICO 147
  • 15.2 EUROPE 151
    • 15.2.1 FRANCE 158
    • 15.2.2 GERMANY 162
    • 15.2.3 ITALY 166
    • 15.2.4 SPAIN 170
    • 15.2.5 U.K. 174
    • 15.2.6 RUSSIA 178
    • 15.2.7 TURKEY 182
    • 15.2.8 SWITZERLAND 186
    • 15.2.9 BELGIUM 190
    • 15.2.10 NETHERLANDS 194
    • 15.2.11 REST OF EUROPE 198
  • 15.3 ASIA-PACIFIC 199
    • 15.3.1 CHINA 206
    • 15.3.2 JAPAN 210
    • 15.3.3 INDIA 214
    • 15.3.4 AUSTRALIA 218
    • 15.3.5 SOUTH KOREA 222
    • 15.3.6 THAILAND 226
    • 15.3.7 PHILIPPINES 230
    • 15.3.8 INDONESIA 234
    • 15.3.9 MALAYSIA 238
    • 15.3.10 SINGAPORE 242
    • 15.3.11 REST OF ASIA-PACIFIC 246

16 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET: COMPANY LANDSCAPE 247

  • 16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 247

17 SWOT ANALYSIS 248

18 COMPANY PROFILE 249

  • 18.1 VARIAN MEDICAL SYSTEMS INC 249
    • 18.1.1 COMPANY SNAPSHOT 249
    • 18.1.2 COMPANY SHARE ANALYSIS 249
    • 18.1.3 PRODUCT PORTFOLIO 250
    • 18.1.4 RECENT DEVELOPMENTS 250
  • 18.2 CARL ZEISS AG 251
    • 18.2.1 COMPANY SNAPSHOT 251
    • 18.2.2 COMPANY SHARE ANALYSIS 251
    • 18.2.3 PRODUCT PORTFOLIO 252
    • 18.2.4 RECENT DEVELOPMENT 252
  • 18.3 ECKERT & ZEIGLER 253
    • 18.3.1 COMPANY SNAPSHOT 253
    • 18.3.2 REVENUE ANALYSIS 253
    • 18.3.3 COMPANY SHARE ANALYSIS 254
    • 18.3.4 PRODUCT PORTFOLIO 254
    • 18.3.5 RECENT DEVELOPMENT 254
  • 18.4 ELEKTA AB 255
    • 18.4.1 COMPANY SNAPSHOT 255
    • 18.4.2 REVENUE ANALYSIS 255
    • 18.4.3 PRODUCT PORTFOLIO 256
    • 18.4.4 RECENT DEVELOPMENT 256
  • 18.5 GMV 257
    • 18.5.1 COMPANY SNAPSHOT 257
    • 18.5.2 COMPANY SHARE ANALYSIS 257
    • 18.5.3 PRODUCT PORTFOLIO 258
    • 18.5.4 RECENT DEVELOPMENT 258
  • 18.6 ARIANE MEDICAL SYSTEMS LTD 259
    • 18.6.1 COMPANY SNAPSHOT 259
    • 18.6.2 PRODUCT PORTFOLIO 259
    • 18.6.3 RECENT DEVELOPMENT 259
  • 18.7 BRAINLAB AG 260
    • 18.7.1 COMPANY SNAPSHOT 260
    • 18.7.2 PRODUCT PORTFOLIO 260
    • 18.7.3 RECENT DEVELOPMENT 260
  • 18.8 ICAD INC. 261
    • 18.8.1 COMPANY SNAPSHOT 261
    • 18.8.2 REVENUE ANALYSIS 261
    • 18.8.3 PRODUCT PORTFOLIO 262
    • 18.8.4 RECENT DEVELOPMENTS 262
  • 18.9 INTRAOP MEDICAL, INC. 263
    • 18.9.1 COMPANY SNAPSHOT 263
    • 18.9.2 PRODUCT PORTFOLIO 263
    • 18.9.3 RECENT DEVELOPMENT 263
  • 18.10 REMEDI CO., LTD. 264
    • 18.10.1 COMPANY SNAPSHOT 264
    • 18.10.2 PRODUCT PORTFOLIO 264
    • 18.10.3 RECENT DEVELOPMENT 264
  • 18.11 SENSUS HEALTHCARE 265
    • 18.11.1 COMPANY SNAPSHOT 265
    • 18.11.2 REVENUE ANALYSIS 265
    • 18.11.3 PRODUCT PORTFOLIO 266
    • 18.11.4 RECENT DEVELOPMENT 266
  • 18.12 SIT - S.I.T. SORDINA IORT TECHNOLOGIES S.P.A. 267
    • 18.12.1 COMPANY SNAPSHOT 267
    • 18.12.2 PRODUCT PORTFOLIO 267
    • 18.12.3 RECENT DEVELOPMENT 267

19 QUESTIONNAIRE 268

20 RELATED REPORTS 272

LIST OF TABLES

  • TABLE 1 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN THE U.S. 54
  • TABLE 2 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN FRANCE 55
  • TABLE 3 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN GERMANY 56
  • TABLE 4 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN CHINA 57
  • TABLE 5 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN JAPAN 58
  • TABLE 6 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN INDIA 59
  • TABLE 7 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN BRAZIL 60
  • TABLE 8 ESTIMATED NUMBER OF NEW CASES FROM 2020 TO 2040, INCIDENCE, BOTH SEXES, AGE [0-85+], IN SOUTH AFRICA 61
  • TABLE 9 AGING WORLD POPULATION 70
  • TABLE 10 UK X RAY DEMAND 2018 76
  • TABLE 11 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION) 80
  • TABLE 12 NORTH AMERICA X-RAY IORT IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 80
  • TABLE 13 THE MOST POPULAR X-RAY IORT IS GIVEN IN THE TABLE BELOW: 81

COMPANY 81

  • TABLE 14 NORTH AMERICA INTRAOPERATIVE BRACHYTHERAPY IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 81
  • TABLE 15 NORTH AMERICA HIGH DOSE-RATE IORT IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 82
  • TABLE 16 NORTH AMERICA ELECTRON IORT IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 83
  • TABLE 17 NORTH AMERICA OTHERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 84
  • TABLE 18 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 88
  • TABLE 19 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 88
  • TABLE 20 THE MOST PROMINENT X-RAY DEVICE USED ARE LISTED IN THE TABLE GIVEN BELOW: 89
  • TABLE 21 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 90
  • TABLE 22 NORTH AMERICA X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 90
  • TABLE 23 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 92
  • TABLE 24 THE MOST PROMINENT APPLICATORS AND THEIR USES HAVE BEEN PROVIDED AT THE TABLE BELOW: 93
  • TABLE 25 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 93
  • TABLE 26 NORTH AMERICA APPLICATORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 94
  • TABLE 27 NORTH AMERICA SOFTWARES & SERVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 95
  • TABLE 28 SOME OF THE POPULAR SOFTWARE AND SERVICES FOR CANCER PATIENTS ARE GIVEN BELOW: 95
  • TABLE 29 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2019-2028 (USD MILLION) 98
  • TABLE 30 NORTH AMERICA PORTABLE IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 98
  • TABLE 31 COMPANIES THAT PROVIDE PORTABLE INTRAOPERATIVE RADIATION THERAPY DEVICES 99
  • TABLE 32 NORTH AMERICA BENCHTOP IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 99
  • TABLE 33 MAJOR RESEARCH STUDIES THAT HAVE UTILIZED BENCHTOP IORT DEVICES 100
  • TABLE 34 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 104
  • TABLE 35 NORTH AMERICA BREAST CANCER IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 104
  • TABLE 36 NORTH AMERICA GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 105
  • TABLE 37 NORTH AMERICA GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 106
  • TABLE 38 NORTH AMERICA SOFT TISSUE SARCOMA IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 107
  • TABLE 39 NORTH AMERICA UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 108
  • TABLE 40 NORTH AMERICA UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 109
  • TABLE 41 NORTH AMERICA GYNACOLOGICAL CANCER IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 110
  • TABLE 42 LIST OF COMMON GYNAECOLOGICAL CANCER 110
  • TABLE 43 NORTH AMERICA BRAIN TUMOR IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 111
  • TABLE 44 NORTH AMERICA HEAD & NECK CANCER IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 113
  • TABLE 45 NORTH AMERICA PAEDIATRICS TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 114
  • TABLE 46 THE OCCURRENCE RATE FOR THE MAJORITY OF PAEDIATRICSS CANCER IN CHILDREN ARE LISTED BELOW: 114
  • TABLE 47 NORTH AMERICA OTHERS CANCER IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 115
  • TABLE 48 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2019-2028 (USD MILLION) 119
  • TABLE 49 NORTH AMERICA HOSPITAL IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 119
  • TABLE 50 NORTH AMERICA SPECIALTY CENTERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 120
  • TABLE 51 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 121
  • TABLE 52 NORTH AMERICA OTHERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 122
  • TABLE 53 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION) 125
  • TABLE 54 NORTH AMERICA DIRECT TENDER IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028 (USD MILLION) 125
  • TABLE 55 NORTH AMERICA RETAIL SALES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY REGION, 2019-2028(USD MILLION) 126
  • TABLE 56 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY COUNTRY, 2019-2028 (USD MILLION) 130
  • TABLE 57 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION) 130
  • TABLE 58 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 130
  • TABLE 59 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 131
  • TABLE 60 NORTH AMERICA X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 131
  • TABLE 61 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 131
  • TABLE 62 NORTH AMERICA APPLICATORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 132
  • TABLE 63 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2019-2028 (USD MILLION) 132
  • TABLE 64 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 132
  • TABLE 65 NORTH AMERICA GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 133
  • TABLE 66 NORTH AMERICA UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 133
  • TABLE 67 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2019-2028 (USD MILLION) 133
  • TABLE 68 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION) 133
  • TABLE 69 U.S. INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION) 134
  • TABLE 70 U.S. INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 134
  • TABLE 71 U.S. INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 134
  • TABLE 72 U.S. X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 135
  • TABLE 73 U.S. INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 135
  • TABLE 74 U.S. APPLICATORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 135
  • TABLE 75 U.S. INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2019-2028 (USD MILLION) 135
  • TABLE 76 U.S. INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 136
  • TABLE 77 U.S. GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 136
  • TABLE 78 U.S. UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 136
  • TABLE 79 U.S. INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2019-2028 (USD MILLION) 137
  • TABLE 80 U.S. INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION) 137
  • TABLE 81 CANADA INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION) 138
  • TABLE 82 CANADA INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 138
  • TABLE 83 CANADA INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 138
  • TABLE 84 CANADA X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 139
  • TABLE 85 CANADA INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 139
  • TABLE 86 CANADA APPLICATORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 139
  • TABLE 87 CANADA INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2019-2028 (USD MILLION) 139
  • TABLE 88 CANADA INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 140
  • TABLE 89 CANADA GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 140
  • TABLE 90 CANADA UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 140
  • TABLE 91 CANADA INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2019-2028 (USD MILLION) 141
  • TABLE 92 CANADA INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION) 141
  • TABLE 93 MEXICO INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2019-2028 (USD MILLION) 142
  • TABLE 94 MEXICO INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 142
  • TABLE 95 MEXICO INTRAOPERATIVE RADIATION THERAPY DEVICES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 142
  • TABLE 96 MEXICO X-RAY INTRAOPERATIVE RADIATION THERAPY SYSTEM IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 143
  • TABLE 97 MEXICO INTRAOPERATIVE RADIATION THERAPY ACCESSORIES IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 143
  • TABLE 98 MEXICO APPLICATORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2019-2028 (USD MILLION) 143
  • TABLE 99 MEXICO INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2019-2028 (USD MILLION) 143
  • TABLE 100 MEXICO INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 144
  • TABLE 101 MEXICO GENITOURINARY CANCERS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 144
  • TABLE 102 MEXICO UPPER GASTRO-INTESTINAL TUMORS IN INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 144
  • TABLE 103 MEXICO INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2019-2028 (USD MILLION) 145
  • TABLE 104 MEXICO INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION) 145

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET : SEGMENTATION 36
  • FIGURE 2 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET: DATA TRIANGULATION 39
  • FIGURE 3 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET : DROC ANALYSIS 40
  • FIGURE 4 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 41
  • FIGURE 5 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET : COMPANY RESEARCH ANALYSIS 41
  • FIGURE 6 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET: INTERVIEW DEMOGRAPHICS 44
  • FIGURE 10 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET: SEGMENTATION 51
  • FIGURE 11 GROWING PREVALENCE OF CANCER DISEASES IS EXPECTED TO DRIVE THE NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET IN THE FORECAST PERIOD OF 2021 TO 2028 52
  • FIGURE 12 INTRAOPERATIVE RADIATION THERAPY DEVICES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET IN 2021 & 2028 52
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET 66
  • FIGURE 14 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY METHOD, 2020 78
  • FIGURE 15 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY PRODUCT, 2020 86
  • FIGURE 16 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY TYPE, 2020 96
  • FIGURE 17 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY APPLICATION, 2020 102
  • FIGURE 18 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY END USER, 2020 117
  • FIGURE 19 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020 123
  • FIGURE 20 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET: SNAPSHOT (2020) 126
  • FIGURE 21 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET: BY COUNTRY (2020) 127
  • FIGURE 22 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET: BY COUNTRY (2021 & 2028) 127
  • FIGURE 23 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET: BY COUNTRY (2020 & 2028) 128
  • FIGURE 24 NORTH AMERICA INTRAOPERATIVE RADIATION THERAPY MARKET: BY METHOD (2021 & 2028) 128